FR2807319B1 - COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT - Google Patents

COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT

Info

Publication number
FR2807319B1
FR2807319B1 FR0004468A FR0004468A FR2807319B1 FR 2807319 B1 FR2807319 B1 FR 2807319B1 FR 0004468 A FR0004468 A FR 0004468A FR 0004468 A FR0004468 A FR 0004468A FR 2807319 B1 FR2807319 B1 FR 2807319B1
Authority
FR
France
Prior art keywords
treatment
cosmetic composition
medicament containing
hematomas
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0004468A
Other languages
French (fr)
Other versions
FR2807319A1 (en
Inventor
Daniel Jean
Leon Cariel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L M D
LMD SAS
Original Assignee
L M D
LMD SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L M D, LMD SAS filed Critical L M D
Priority to FR0004468A priority Critical patent/FR2807319B1/en
Priority to AU2001246631A priority patent/AU2001246631A1/en
Priority to PCT/FR2001/000883 priority patent/WO2001076551A1/en
Publication of FR2807319A1 publication Critical patent/FR2807319A1/en
Application granted granted Critical
Publication of FR2807319B1 publication Critical patent/FR2807319B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0004468A 2000-04-07 2000-04-07 COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT Expired - Fee Related FR2807319B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0004468A FR2807319B1 (en) 2000-04-07 2000-04-07 COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT
AU2001246631A AU2001246631A1 (en) 2000-04-07 2001-03-23 Cosmetic or pharmaceutical composition containing a sesquiterpene lactone
PCT/FR2001/000883 WO2001076551A1 (en) 2000-04-07 2001-03-23 Cosmetic or pharmaceutical composition containing a sesquiterpene lactone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004468A FR2807319B1 (en) 2000-04-07 2000-04-07 COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT

Publications (2)

Publication Number Publication Date
FR2807319A1 FR2807319A1 (en) 2001-10-12
FR2807319B1 true FR2807319B1 (en) 2004-10-22

Family

ID=8848990

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0004468A Expired - Fee Related FR2807319B1 (en) 2000-04-07 2000-04-07 COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT

Country Status (3)

Country Link
AU (1) AU2001246631A1 (en)
FR (1) FR2807319B1 (en)
WO (1) WO2001076551A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843125B1 (en) 2002-08-02 2012-11-16 Coletica ACTIVE PRINCIPLES STIMULATING HUMAN BETA-DEFENSIVE TYPE 2 AND / OR TYPE 3, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS
FR2861293B1 (en) * 2003-10-22 2008-10-17 Greenpharma Sas COMPOSITION FOR PREVENTING OR TREATING DISORDERS RESULTING FROM A CELL DEATH PROCESS COMPRISING A SESQUITERPENIC LACTONE
FR2900820B1 (en) * 2006-05-10 2008-10-03 Dermatologiques D Uriage Lab USE OF PLANT EXTRACTS FOR COSMETIC OR DERMATOLOGICAL PURPOSES AND COMPOSITIONS CONTAINING THESE EXTRACTS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789002A (en) * 1971-09-22 1973-01-15 Sori Soc Rech Ind PROCESS FOR OBTAINING AN EXTRACT OF ARNICA MONTANA
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
JPH05306231A (en) * 1992-04-24 1993-11-19 Pola Chem Ind Inc Skin external preparation
CA2283122A1 (en) * 1997-03-03 1998-09-11 Laboratoires Remilea Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
US5804206A (en) * 1997-03-06 1998-09-08 Bio-Botanica, Inc. Therapeutic composition and method for treating skin using Centipeda cunninghami extract
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5976547A (en) * 1997-04-22 1999-11-02 Niblick Pharmaceuticals, Inc. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
JPH1149686A (en) * 1997-08-01 1999-02-23 Lion Corp Blue bruise skin lotion

Also Published As

Publication number Publication date
WO2001076551A1 (en) 2001-10-18
AU2001246631A1 (en) 2001-10-23
FR2807319A1 (en) 2001-10-12
WO2001076551B1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
MA26889A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE CHRONIC AND / OR NEUROPATHIC PAIN AND MIGRAINES
CH689805A8 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
BR0309890A (en) Pharmaceutical composition containing blood plasma or blood serum used in the treatment of lesions, as well as its method and application process
BR9608500A (en) Use of at least one extract of at least one non-photosynthetic filamentous bacterium cosmetic or pharmaceutical composition and cosmetic treatment process
DZ2074A1 (en) New formulation containing paroxetine, and process for its preparation.
KR980000419A (en) Cosmetic pigment composition for preventing hair loss and a method for producing the composition
FR2715844B1 (en) Emulsion containing stabilized ascorbic acid, cosmetic treatment process using it, its uses.
FR2730930B1 (en) USE OF NO-SYNTHASE INHIBITORS TO REDUCE THE IRRITANT SKIN EFFECT OF PRODUCTS USED IN THE COSMETIC OR PHARMACEUTICAL FIELD
TNSN97073A1 (en) MESYLATE TRIHYDRATE 5- (2- (4- (1,2-BENZISOTHIAZOLE-3-YL) -1- PIPERAZINYL) -ETYL) -6-CHLORO-1,3-DIHYDRO-2 H-INDOLE-2-ONE , PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BR9610375A (en) Cell extract cosmetic or pharmaceutical composition use of at least one cell extract and cosmetic treatment process
CA2206837A1 (en) Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis
BR0317358A (en) Pyrrolopyridazine compound, process for its preparation, pharmaceutical composition containing same, method of prevention or treatment of diseases containing same and their use
BRPI0409523A (en) method for treating neuropathic pain, method of identifying a compound and pharmaceutical composition
TNSN96104A1 (en) (1S, 2S) -1- (4-HYDROXYPHENYL) -2- (4-HYDROXY-4-PHENYLPIPERIDINE-1-YL) -1-PROPANOL TRIHYDRATE METAHENSULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
ATE238792T1 (en) USE OF MACROLIDS TO TREAT GLAUCOMA
FR2813306B1 (en) AMINOALKYBENZOYL-BENZOFURANS OR BENZOTHIOPHENES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME
DZ2709A1 (en) Synthetic polysaccharides process for their preparation and pharmaceutical compositions containing them.
DZ2680A1 (en) Thiazolidinedione derivative novel process for its preparation and pharmaceutical composition containing it.
AR004326A1 (en) USE OF AT LEAST ONE TNF-ALPHA ANTAGONIST, COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION CONTAINING SUCH ANTAGONIST AND COSMETIC DETREATMENT PROCEDURE USING SUCH ANTAGONIST.
BR9712141A (en) Application of 1-hyphroxy-2-pyridones to treat skin infections.
FR2807319B1 (en) COSMETIC COMPOSITION OR AS A MEDICAMENT CONTAINING A SESQUITERPENIC LACTONE FOR TREATING HEMATOMAS, AND METHOD OF TREATMENT
DZ2701A1 (en) New mmp inhibitor compounds, process for their preparation and pharmaceutical compositions containing them.
FR2730635B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, CONTAINING BERTHOLLETIA EXTRACT
DE69925578D1 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES RELATED TO EYE-BASED CELL-DISEASES
BR0006301A (en) Antibacterial and prokinetic macrolides

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20051230